Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | SCN4A | P35499 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17395999 | 0.85 | LMNA (0.50) | LMNALTA4HMAOAPTGS1MTNR1A | |
| SCHEMBL29184943 | 0.83 | PLA2G2A (0.54) | LMNACYP2C9TSHRLTA4H | |
| SCHEMBL27817067 | 0.82 | LMNA (0.47) | LMNACYP2C9TSHRMAOAPTGS1 | |
| SCHEMBL3081620 | 0.81 | TSHR (0.73) | LMNACYP2C9TSHRMAOAPTGS1 | |
| SCHEMBL15801032 | 0.81 | TSHR (0.73) | LMNACYP2C9TSHRMAOAPTGS1 | |
| SCHEMBL17036999 | 0.80 | TSHR (0.49) | LMNACYP2C9TSHRALDH1A1 | |
| SCHEMBL11121696 | 0.79 | LMNA (0.52) | LMNACYP2C9TSHRMAOAPTGS1 | |
| SCHEMBL30173401 | 0.79 | LMNA (0.52) | LMNACYP2C9TSHRMAOAPTGS1 | |
| SCHEMBL17037001 | 0.79 | ALDH1A1 (0.51) | LMNACYP2C9TSHRALDH1A1TDP1 | |
| SCHEMBL7567777 | 0.78 | LMNA (0.60) | LMNALTA4HMAOAPTGS1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120232169-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | BIOZONE PHARMACEUTICALS, INC. (US) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232169-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | LIPA, CETP, DGAT2 | LMNA 3678/4885CYP2C9 1346/4885TSHR 3494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.